I too haven't been happy as all would know and have posted on...

I too haven't been happy as all would know and have posted on here the many failings of PAA as I saw it.
But we also have to remember that a lot of the information being used by MT was actually as a direct result of actions taken by the out going BODs and RM and in some way even going back to Professor Morris.
Possible PPL / MPL use against cancer - Professor Morris / RA and RM.

The canine cancer can also be as above
The MND funding, trial and ODD etc was the outgoing board

The trial its self was carried out by The two centres

Possible use of MPL in other diseases has all been done by the out going board.

So really all MT had to do was getting funding to keep PAA afloat (which he did), deliver the good results from the trial, submit the ODD application and possibly arrange the extension trial along with the phase 2 / 3 trial.

Now it was becoming clear that the phase 2 / 3 trial was unlikely to commence by end of June as time went by.

Maybe some on here knew what was going on in the back ground but I for one didn't and still don't know.

But I am at a loss to believe that with the resignation of the CEO and then the resignations (at the request of some shareholders) of most of the board, how any one could not have predicted the drop in the shareprice.